Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Joshua Smith

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
Nature Communications|February 2, 2021
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitorsCristina Valero, Mark Lee, Douglas Hoen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2020
Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant ChemotherapyAndrea Cercek, Gustavo Dos Santos Fernandes, Campbell S Roxburgh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2018
SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and ChemoresistanceIsaac Wasserman, Lik Hang Lee, Shuji Ogino, et al.
Nature Communications|February 26, 2026
Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinomaPaul B Romesser, Aron Bercz, Janet Alvarez, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2022
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant TherapyJulio Garcia-Aguilar, Sujata Patil, Marc J Gollub, et al.
The New England Journal of Medicine|April 28, 2025
Nonoperative Management of Mismatch Repair-Deficient TumorsAndrea Cercek, Michael B Foote, Benoit Rousseau, et al.
Journal of the National Cancer Institute|August 18, 2021
A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal CancersAndrea Cercek, Walid K Chatila, Rona Yaeger, et al.
Nature Communications|November 25, 2021
Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insightsOlusegun Isaac Alatise, Gregory C Knapp, Avinash Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA TrialFloris S Verheij, Dana M Omer, Hannah Williams, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Nature Communications|February 2, 2021
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitorsCristina Valero, Mark Lee, Douglas Hoen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2020
Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant ChemotherapyAndrea Cercek, Gustavo Dos Santos Fernandes, Campbell S Roxburgh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2018
SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and ChemoresistanceIsaac Wasserman, Lik Hang Lee, Shuji Ogino, et al.
Nature Communications|February 26, 2026
Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinomaPaul B Romesser, Aron Bercz, Janet Alvarez, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2022
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant TherapyJulio Garcia-Aguilar, Sujata Patil, Marc J Gollub, et al.
The New England Journal of Medicine|April 28, 2025
Nonoperative Management of Mismatch Repair-Deficient TumorsAndrea Cercek, Michael B Foote, Benoit Rousseau, et al.
Journal of the National Cancer Institute|August 18, 2021
A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal CancersAndrea Cercek, Walid K Chatila, Rona Yaeger, et al.
Nature Communications|November 25, 2021
Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insightsOlusegun Isaac Alatise, Gregory C Knapp, Avinash Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA TrialFloris S Verheij, Dana M Omer, Hannah Williams, et al.
Pageof 19